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Aging is a complex process resulting in decreased tissue 
function, and cellular and molecular damage. Adult 
stem cells that self-renew and maintain progenitors that 
appropriately differentiate into functional cell types are 
essential to maintain tissue homeostasis and repair 
throughout lifespan [1]. Aging-associated exhaustion 
and dysfunction have  been  reported  in  highly  prolife- 
 
 
rative hematopoietic stem cells (HSC) [2], hair follicle 
stem cells (HFSC) [3], muscle stem cells [4] and 
adipose-derived mesenchymal stem cells [5]. Reduced 
stem cell function contributes to aging associated 
degenerative diseases [6], and is associated with 
molecular changes including accumulation of reactive 
oxygen species (ROS) [7], defects in cell cycle 
regulation [8] and cellular senescence [5]. 


























tested the hypothesis that aging promotes  IESC dysfunction using old  (18‐22 months) and young  (2‐4 month)
Sox9‐EGFP  IESC  reporter mice. Different  levels  of  Sox9‐EGFP  permit  analyses  of  active  IESC  (Sox9‐EGFPLow),
activatable  reserve  IESC  and  enteroendocrine  cells  (Sox9‐EGFPHigh),  Sox9‐EGFPSublow  progenitors,  and  Sox9‐
EGFPNegative differentiated lineages. Crypt‐villus morphology, cellular composition and apoptosis were measured
by histology.  IESC  function was assessed by crypt culture, and proliferation by  flow cytometry and histology.
Main findings were confirmed in Lgr5‐EGFP and Lgr5‐LacZ mice. Aging‐associated gene expression changes were
analyzed by Fluidigm mRNA profiling. Crypts culture from old mice yielded fewer and  less complex enteroids.
Histology  revealed  increased villus height and Paneth cells per crypt  in old mice. Old mice showed  increased
numbers  and  hyperproliferation  of  Sox9‐EGFPLow  IESC  and  Sox9‐EGFPHigh  cells.  Cleaved  caspase‐3  staining
demonstrated increased apoptotic cells in crypts and villi of old mice. Gene expression profiling revealed aging‐
associated  changes  in mRNAs  associated with  cell  cycle,  oxidative  stress  and  apoptosis  specifically  in  IESC.
These  findings  provide  new,  direct  evidence  for  aging  associated  IESC  dysfunction,  and  define  potential
biomarkers and targets for translational studies to assess and maintain IESC function during aging. 
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Rapid renewal of the intestinal epithelium is driven by 
resident intestinal epithelial stem cells (IESC). IESC 
divide to self-renew and generate progenitor cells that 
undergo rapid proliferation followed by terminal 
differentiation into cell types including enterocytes, 
Paneth cells, goblet cells and enteroendocrine cells 
(EEC) [9]. Differentiated cells perform absorptive, 
barrier, antimicrobial and secretory functions, and 
endocrine and metabolic regulatory functions essential 
to health. In Drosophila, aging is associated with 
increased IESC number and proliferation, and IESC 
dysfunction, including activation of stress response 
pathways such as JNK [10] and p38-MAPK [11]. In 
mammals, it has been demonstrated that aging is 
associated with decreased intestinal barrier function 
[12], impaired nutrient absorption [13], small bowel 
bacterial overgrowth [14] and increased risk of 
gastrointestinal (GI) cancers [15, 16]. Previous reports 
in mouse models of accelerating aging indicate 
phenotypic changes in the intestinal epithelium 
including defective regeneration, cell cycle dys-
regulation [17] and altered Wnt signaling [18], 
indicating that aging may inhibit IESC/progenitor cell 
maintenance or function.  
 
Prior studies in rodent models suggest that aging may be 
associated expansion of IESC or progenitor cells, but 
with reduced capacity for tissue repair following injury 
[19-22]. However, the direct effects of aging on IESC 
could not be examined in these studies due to a lack of 
IESC specific biomarkers to permit direct IESC 
visualization, isolation and functional analyses. The 
identification of specific biomarkers of IESC such as 
Lgr5 [23] and the development of fluorescent IESC 
reporter mice allow direct IESC evaluation in vivo and 
IESC isolation for ex vivo studies and molecular analyses 
[9]. Sox9-EGFP reporter mice provide a useful model 
because distinct levels of enhanced green fluorescent 
protein (EGFP) expression mark different intestinal 
epithelial cell (IEC) populations [24, 25]. Sox9-EGFPHigh 
cells are hormone-producing EEC and cells with 
functional characteristics of activatable, reserve IESC 
[25, 26]. Sox9-EGFPLow cells are active IESC also 
termed crypt based columnar cells (CBC) [23, 27]. Sox9-
EGFPLow cells have been functionally validated as IESC 
based on the ability of single Sox9-EGFPLow cells to form 
enteroids in vitro when isolated from uninjured small 
intestine [24, 25, 28]. Sox9-EGFPLow cells are enriched 
for Lgr5 mRNA and many other mRNAs expressed at 
high levels in Lgr5-expressing IESC-CBC [25, 29]. 
Sox9-EGFPSublow cells are rapidly dividing progenitor 
cells that give rise to differentiated progeny [24, 25]. 
Sox9-EGFPNegative cells contain differentiated IEC, 
particularly absorptive enterocytes, Paneth cells and 
goblet cells [25], based on histologic analysis and high 
level expression of biomarkers of these cell types.  
This study used Sox9-EGFP, Lgr5-EGFP and Lgr5-
LacZ reporter models to test the hypothesis that aging 
leads to IESC dysfunction and altered intestinal 
epithelial homeostasis. Results reveal new and direct 
evidence for IESC dysfunction in old mice associated 
with IESC hyperproliferation and expansion but 
increased apoptosis.  These functional changes in IESC 
were associated with altered expression of mRNAs 
encoding proteins and pathways that stimulate cell cycle 
progression, DNA damage and apoptosis specifically in 
IESC, providing new biomarkers and potential 




Aging-associated decreases in enterosphere 
formation and enteroid development 
 
Crypt culture in a 3D matrigel system provides a useful 
and widely used system to assess IESC function [30]. 
Isolated intestinal crypts form round enterospheres that 
expand and differentiate to form more complex 
enteroids with bud structures after several days in 
culture [31]. Crypt culture revealed that intestinal crypts 
isolated from both young and old animals formed 
enterospheres in vitro on day 1 after plating (Figure 
1A). Efficiency of crypt culture was calculated by 
dividing the number of enterospheres and enteroids 
present at day 4 or 8 by the number of enterospheres 
present on day 1 in each well. This provides a 
measurement of how many enterospheres initially 
plated were able to survive and grow in crypt culture 
conditions. Efficiency measurements revealed a trend 
for decreased enteroid survival in old vs. young at day 4 
post plating and a significant decrease in enteroid 
survival in old animals at day 8 post plating (Figure 
1B). Crypt-derived enteroids typically begin to show 
bud structures by 3-7 days post plating [31]. Each bud 
represents a crypt structure that containing stem and 
progenitor cells and the number of buds provide a 
surrogate for IESC function [32]. The numbers of buds 
per enteroid were counted at days 4 and 8 post plating, 
categorizing enteroids with 2 buds or fewer as less 
complex, and enteroids containing 3 or more buds as 
more complex. Following 4 days in culture there was no 
difference in the enteroid complexity between young 
and old (Figure 1C). By day 8 post plating, enteroids 
from old mice showed a decrease in complexity 
compared to those from young mice as significantly 
fewer enteroids from old animals contained 3 or more 
buds (Figure 1C). At 15 days post plating very complex 
enteroids had formed from the crypts derived from 
young mice, while the enteroids formed from old mice 
were much less complex (Figure 1A).  




















































































































Measure Young Old 
 Mean (SEM) Mean (SEM) 
Crypt Depth (µm) 50.7 (1.8) 50.6 (2.5) 
Total # epithelial cells per crypt 34 (3) 30 (1) 
Villus Height (µm) 263.2 (26.1) 361.7* (30.0) 
Crypt Density (crypts/cm) 145 (18) 159 (19) 
Villus Density (villi/cm) 40 (5) 42 (3) 
Circumference (cm) 0.97  (0.06) 0.96  (0.05) 
# Lysozyme+ Paneth cells/crypt 3.6 (0.2) 4.3* (0.1) 
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Increased villus height and Paneth cell number in 
small intestine of old mice 
         
Jejunal morphology and morphometry and the presence 
of differentiated cell types were assessed by histology. 
Results revealed no significant difference in crypt 
depth, crypt or villus density, total number of cells per 
crypt, or mucosal circumference between young and old 
mice, but demonstrated a significant increase in villus 
height in old vs. young mice (Table 1 and Figure 2A). 
Immunofluorescence for lysozyme, a Paneth cell bio-
marker, revealed a small but significant increase in the 
number of Paneth cells per crypt in old vs. young (Table 
1 and Figure 2B). Alcian Blue positive goblet cells were 
quantified and revealed no change in the number of 
mucus producing goblet cells between the young and 
old mice (Table 1 and Figure 2C).  
 
Old mice exhibit increased IESC number and 
enhanced IESC proliferation 
         
Flow cytometry on IEC isolated from Sox9-EGFP mice 
revealed significantly more IESC (Sox9-EGFPLow) and 
progenitor cells (Sox9-EGFPSublow)  in  old  vs. to  young  
































population that contains enteroendocrine cells (EECs) 
and a reserve stem cell population activatable upon 
injury and regeneration [25] did not differ between 
young and old mice (Figure 3A and 3B). Results were 
confirmed by EGFP immunofluorescence, which 
revealed no change in the number of Sox9-EGFPHigh 
cells per crypt in old vs. young (Figure 3C and 3E) but 
demonstrated a significant increase in the number of 
Sox9-EGFPLow IESC per crypt in old animals (Figure 
3C and 3D). This was further confirmed in the Lgr5-
LacZ IESC reporter mouse model [23] where expansion 
of Lgr5-LacZ IESC was observed in old  vs. young 
(Figure 3F and 3G). Of note, using histology it is not 
possible to reliably quantify Sox9-EGFPSublow 
progenitor cells by EGFP immunofluorescence because 
the very low EGFP expression cannot be readily 
distinguished from background. 
         
Flow cytometry of dissociated jejunal IEC from young 
and old Sox9-EGFP reporter mice detected 
incorporation of the S-phase marker EdU in 3 distinct 
EGFP-expressing cell populations (Figure 4B). As 
expected, rapidly dividing Sox9-EGFPSublow progenitor 
cell population showed the most EdU positive cells 


















































































Based on percentage of cells incorporating EdU, 
there was no detectable difference in proliferation of 
Sox9-EGFPSublow progenitors between young 
(33.7±2.7%) and old (37.6±5.0%) (Figure 4). How-
ever, there was a significant increase in the percentage 
of EdU-positive Sox9-EGFPLow IESC in old 
(39.5±4.3%) vs. young (26.3±3.8%), indicating 
hyperproliferation of IESC in old mice. The 
percentage of EdU-labeled Sox9-EGFPHigh cells was 
significantly higher in old (7.8±1.6%) vs. young 
(2.4±0.5%) (Figure 4). This provides evidence that old 
mice have a greater proportion of “activatable reserve” 
IESC in S phase. 











































Immunofluorescence for EdU revealed no difference in 
the total number of EdU positive cells per crypt in old vs. 
young (Figure 4C, 4D). However, co-immunofluores-
cence for EdU and GFP revealed a significant increase in 
the number of EdU positive Sox9-EGFPLow IESC located 
at the crypt base in old mice (Figure 4C, 4D). Results 
were confirmed in an independent IESC reporter mouse 
model, Lgr5-EGFP [23] (Figure 5A-C), which revealed 
significantly more Lgr5-EGFP IESC co-labeled with 
EdU in old (2.3±0.2) vs. young (1.5±0.2) (Figure 5C). 
Together these data provide strong evidence that aging is 
associated with a selective increase in proliferation and/or 
altered cell cycle dynamics in IESC of old mice. 
Figure 3. Increased IESC in old mice. (A) Representative flow cytometry data of Sox9‐EGFP expressing cells in young
and old Sox9‐EGFP reporter mice. Gate: R3=Sox9‐EGFPHigh, R4=Sox9‐EGFPLow, R5=Sox9‐EGFPSublow. (B) Relative abundance
of different Sox9‐EGFP expressing  cells measured by  flow  cytometry. n=19 animals per group, *p<0.05 Young vs. Old,
unpaired  t  test.  (C) Representative  images of crypt sections  from young and old Sox9‐EGFP  reporter mice stained with




sections  from young and old Lgr5‐LacZ  reporter mice. Magnification : 40x, Scale bar : 20µm.    (G) Quantification of  the
number of Xgal stained Lgr5‐LacZ IESC counted per crypt section. n=4, p<0.05 Young vs. Old, unpaired t test. 










































Old mice exhibit increased apoptosis of the small 
intestinal epithelial cells 
         
Given the age-associated IESC dysfunction indicated by 
our results in the ex vivo enteroid culture system, we 
tested whether apoptosis was increased in the small 
intestinal crypt of old vs. young mice. Cleaved caspase-
3 immunohistochemistry revealed a significant increase 
in the number of apoptotic cells per crypt section in old 
vs. young (Figure 6A, 6B-right and 6C). The location of 
cleaved caspase-3 positive cells within the crypt was 
assessed by dividing the crypt in half lengthwise and 
counting the position of apoptotic cells from the base of 
the crypt (Figure 6D). Most apoptotic cells in old 










































(Figure 6C and 6D), indicating preferential increases in 
apoptosis within the IESC zone. Old mice showed a 
significant increase in cleaved caspase-3 positive cells 
in the villi (Figure 6A and 6B-left), that were strikingly 
located along the villus epithelium rather than the villus 
tip.  
 
Aging-associated changes in gene expression 
         
To gain insight into molecular mechanisms or 
biomarkers of age associated functional changes in 
IESC and other cell populations between old and young 
mice, we used FACS (Fluorescence Activated Cell 
Sorting) coupled with Fluidigm mRNA profiling. First 
we validated that profiles of  Sox9  mRNA  and  biomar- 
Figure 4. Old mice exhibit increased proportion of Sox9‐EGFPLow IESC and Sox9‐EGFPHigh cells in S‐phase as assessed
by flow cytometry and histology. (A and B) Relative abundance of Sox9‐EGFP expressing populations that have  incorporated
EdU  was  measured  by  flow  cytometry.  n=6  animals  per  group,  *p<0.05  Young  vs.  Old,  unpaired  t  test.
(C)  Representative  images  of  crypt  sections  from  young  and  old  Sox9‐EGFP mice  stained with  EGFP,  S‐phase marker  EdU  and
nuclear marker DAPI. Closed arrows  indicate Sox9‐EGFPLow  IESC  in S‐phase. (D) Number of total crypt cells  incorporating EdU per
Sox9‐EGFP crypt section. n=6 animals per group. (E) Number of Sox9‐EGFPLow IESC incorporating EdU per crypt section. n=6 animals
per group, *p<0.05 Young vs. Old, unpaired t test.  
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kers of specific IEC subtypes exhibited predicted 
profiles in isolated cell populations from young and old 
Sox9-EGFP mice (Figure 7A-D). Our data verified that 
the expression profiles of Sox9 mRNA in FACS-
isolated cells matched the profiles of Sox9-EGFP used 
to FACS isolate cell populations (Figure 7A). 
Furthermore, Sox9 mRNA profiles across Sox9 
negative, sublow, low and high populations were 
consistent between young and old. The IESC specific 
marker Lgr5 was enriched in the Sox9-EGFPLow 
population from both young and old, consistent with 
phenotypic similarities between Sox9-EGFPLow and 
Lgr5-EGFP-expressing IESC (Figure 7B). Sox9-
EGFPHigh populations from young and old were 
enriched for EEC specific mRNA ChgA (Figure 7C) 
and Hopx, a putative biomarker of activatable reserve 
IESC (Figure 7D). To gain insight into the mechanisms 
driving aging-associated IESC expansion and hyper-






































volved in cell cycle, apoptosis and maintenance of 
homeostasis in cell populations isolated from Sox9-
EGFP mice. Consistent with histology and flow 
cytometry data suggesting increased proportion of  
active Lgr5-expressing and activatable reserve IESC in 
S-phase in old mice, we observed a significant increase 
in Ccnd1 and Cdk6 mRNAs in Sox9-EGFPLow cells and 
a dramatic increase in Ccnd1 mRNA in Sox9-EGFPHigh 
cells from old vs. young (Table 2A, 2B). Ccnd1 and 
Cdk6 are required for cell cycle progression and activate 
G1 to S phase transition [33, 34]. Additional mRNAs 
involved in regulating the cell cycle and proliferation 
were significantly different in cell populations from old 
vs. young including Max in Sox9-EGFPHigh and p21 in 
Sox9-EGFPLow (p21) (Table 2A, 2B). Consistent with 
increased levels of apoptosis observed based on 
localization of cleaved caspase-3 in the crypt base of 
old animals, Fluidigm data revealed increased levels of 











































animals.  (C). Number of Lgr5‐EGFP  IESC  incorporating EdU per crypt section. n=5 young and 6 old
animals, *p<0.05 Young vs. Old, unpaired t test. Magnification: 40x, Scale bar : 20µm for all images. 
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EGFPLow IESC from old mice (Table 2B). We found a 
significant increase in the mRNA encoding Nrf2, a 
marker of oxidative stress, in Sox9-EGFPLow IESC from 
old mice (Table 2B). Significantly decreased levels of 
mRNAs associated with proliferation, apoptosis and 
homeostasis were observed in the old  Sox9-EGFPSublow 
progenitor cell population, including Pten, Yap1, 
Ephb2, Notch2 and Bbc3 (Table 2C). H2afx mRNA 
levels were increased specifically in Sox9-EGFPNegative 
cells from old mice, consistent with and providing a 
potential biomarker of age-associated increases in 
apoptosis of differentiated cells on the villus. Decreased 
levels of mRNAs known to be associated with tissue 
homeostasis with aging in Sox9-EGFPNegative cells from 
old mice are consistent with increases in villus height, a 




Until 2007 the study of IESC and the effect of aging on 
IESC was hampered by a lack of specific biomarkers. 
Our findings in the Sox9-EGFP reporter mouse, 
confirmed in Lgr5-EGFP and Lgr5-LacZ reporter mice 

































associated with increases in IESC number, proliferation, 
and increases in IESC apoptosis in vivo and functional 
impairment of isolated IESC in vitro. Our findings of 
increased villus height and expansion of Paneth cells in 
old mice indicate altered intestinal homeostasis with 
aging. 
         
Consistent with our findings, aging-associated changes 
in small intestinal morphology including increased in 
villus height have been reported in mice [35], rats [36] 
and  humans [37]. Previous findings that old rats exhibit 
decreased absorption of fatty acids and glucose indicate 
aging-associated functional impairment in nutrient 
absorption [38]. Aging-associated increases in villus 
height may therefore represent a compensatory 
mechanism to reduce risk of malnutrition with aging. 
Our results showing increased cleaved caspase-3 
positive cells on villi of old mice provide additional 
support for aging-associated functional impairment of 
differentiated enterocytes. Our findings also support a 
model where increased villus height in old animals is 
maintained by an expanded pool of hyperproliferative 
IESC that is needed to generate additional differentiated 

































Figure 6.  Increased proportion of small  intestinal epithelial cell apoptosis with age. (A) Representative  image of crypt
and  villus  sections  stained  for  cleaved  caspase‐3. Magnification  :  10x,  Scale bar  :  100µm  .  (B) Quantification of  the number of
cleaved caspase‐3 positive cells per villus section  (n=7 animals per group) and per crypt section  (n=10 young and 9 old animals).
*p<0.05 Young vs. Old, unpaired t test. (C) Representative image of crypt sections stained for cleaved caspase‐3. Magnification: 40x,
Scale bar  : 20µm. (D) Quantification of the  location of cleaved caspase‐3 positive cells per 40 crypts per animal by position.  Inlay
shows method of identifying cell position within crypt. n=10 young and 9 old animals, *p<0.05 Young vs. Old, unpaired t test. 


















































































































A. Sox9-EGFP High Gene Regulation 
mRNAs upregulated specifically in Sox9-EGFP High cells 
Symbol Gene name Fold Change Role 
Ccnd1 cyclin D1 >10 cell cycle progression [33] 
Max MYC associated factor X 1.97 regulates proliferation [57] 
mRNAs downregulated specifically in Sox9-EGFP High cells 
Symbol Gene name Fold Change Role 
Irs1 insulin receptor substrate 1 -2.09 deficiency induces ISC apoptosis [58] 
B. Sox9-EGFP Low Gene Regulation 
mRNAs upregulated specifically in Sox9-EGFP Low cells 
Symbol Gene name Fold Change Role 
p53 tumor protein 53 >10 induces apoptosis [59] 
Nrf2 nuclear factor, erythroid derived 2, like 
2 
2.62 protects against oxidative stress [60] 
Cdk6 cyclin-dependent kinase 6 2.43 cell cycle progression [34] 
Ccnd1 cyclin D1 2.3 cell cycle progression [33] 
Perp TP53 apoptosis effector 1.94 induces apoptosis [52] 
mRNAs downregulated specifically in Sox9-EGFP Low cells 
Symbol Gene name Fold Change Role 
Cdkn1A/p21 cyclin-dependent kinase inhibitor 1A -2.16 inhibits proliferation [61] 
C. Sox9-EGFP Sublow Gene Regulation 
mRNAs downregulated specifically in Sox9-EGFP Sublow cells
Symbol Gene name Fold Change Role 
Pten phosphatase and tensin homolog -1.26 regulates ISC proliferation [62] 
Yap1 yes-associated protein 1 -1.81 regulates proliferation and homeostasis [63] 
Ephb2 EPH receotpr B2 -2.19 promotes proliferation and controls migration 
[64] 
Notch2 notch 2 -2.68 regulates intestinal homeostasis and 
differentiation [65] 
Bbc3/Puma BCL2 binding component 3 -3.31 deficiency blocks apoptosis [66] 
D. Sox9-EGFP Negative Gene Regulation 
mRNAs upregulated specifically in Sox9-EGFP Negative cells 
Symbol Gene name Fold Change Role 
H2afx H2A histone family, member X 3.4 DNA damage repair [67] 
mRNAs downregulated specifically in Sox9-EGFP Negative cells
Symbol Gene name Fold Change Role 




isolated  from old versus young Sox9‐EGFP mice, and  the  fold change  in old versus young mice. A. Sox9‐EGFPHigh activatable 
reserve  IESC/enteroendocrine  cell  populations;  B.  Sox9‐EGFPLow  IESC;  C.  Sox9‐EGFPSublow  progenitor  cells  and  D.  Sox9‐
EGFPNegative  progenitor  cells.  In  each  cell  population,  values  normalized  to  a  pooled  unsorted  sample were  compared  for 
statistical difference between Young vs Old cells; n≥3 animals per group; p<0.05 was considered significant. The Tables show 
the fold difference for statistically different mRNAs in specific cell populations from old vs. young mice.  

































Paneth cells release trophic factors in the IESC niche, 
contribute to maintained IESC function [39], and 
secrete antimicrobial peptides to provide host defense 
against microbes [40]. Age-associated increases in 
bacterial load have been reported in the intestinal lumen 
of Drosophila and were associated with increased IESC 
proliferation [41]. Furthermore, previous studies in mice 
and humans reported changes in intestinal microbiome 
with age including changes in proportion of major 
microbes and decreased overall microbiota diversity 
[42, 43]. Our observed increases in Paneth cell number 
in old mice therefore suggest an adaptive response that 
may promote IESC expansion and could reflect age-
associated changes in microbiota. 
         
Our findings in the Sox9-EGFP mouse model and 
confirmative data in Lgr5-EGFP and Lgr5-LacZ IESC 
provide, to our knowledge, the first direct evidence for 
age-associated expansion and hyperproliferation of 
mammalian IESC. Our findings that crypts from old 
animals have reduced enteroid forming ability and yield 
enteroids with reduced complexity compared with ente-
roids formed from young crypts provide new evidence 

































The Sox9-EGFP mouse model offers the opportunity to 
study and isolate progenitor cells (Sox9-EGFPSublow) 
and Sox9-EGFPHigh cells that contain EEC cells and an 
activatable reserve stem cell population [25]. A recent 
study suggested that subsets of secretory EEC cells can 
act as reserve stem cells in humans [45]. Interestingly, 
we observed an increased proportion of Sox9-EGFPHigh 
cells in S phase of the cell cycle in old mice, yet no 
expansion in cell number. This provides novel evidence 
that aging is associated with activation and proliferation 
of reserve stem cells as a mechanism to maintain 
epithelial renewal during aging. 
         
Based on in vivo findings of aging-associated IESC 
hyperproliferation and increased apoptosis in the stem 
cell zone of the crypt, we assessed levels of mRNAs 
encoding proteins linked to cell cycle regulation, 
oxidative stress, DNA damage and apoptosis in the 
different Sox9-EGFP cell populations isolated from 
young and old mice (Probes for mRNAs showing 
significant differences between cells from young and 
old mice are described in Supplementary Table 1). Sox9-
EGFPHigh cells and Sox9-EGFPLow IESC from old mice 







































that accelerate G1 to S phase transition including 
Ccnd1, Cdk6, Max and Mlx [46]. IESC hyper-
proliferation may increase the probability of genomic 
instability, triggering a DNA damage response and 
apoptosis [46]. Elevation of Nrf2 mRNA in Sox9-
EGFPLow IESC from old mice adds support to a model 
of aging-associated cellular and molecular damage in 
IESC [48, 49]. Nrf2 promotes accumulation of reactive 
oxygen species (ROS), which causes DNA damage, and 
has been linked to aging in both drosophila and 
mammals [47].  Elevation of mRNAs encoding proteins 
known to stimulate cell apoptosis including p53, Sirt7, 
Max, Bak1 and Bax in actively cycling Sox9-EGFPLow 
IESC provide new evidence for IESC-specific 
mediators linked to IESC dysfunction. p53 is induced in 
response to DNA damage or cellular stress and activates 
cell cycle arrest, apoptosis or senescence pathways [50, 
51]. Our observed induction of both p53 mRNA and the 
downstream mediator, Perp [52, 53] in old IESC 
support a model of aging-linked oxidative stress and 
DNA damage-induced apoptosis. Overall, mRNA 
profiling data on young and old IESC and differentiated 
lineages provide new evidence that aging is associated 

































regulation of cell cycle, proliferation, apoptosis, DNA 
damage and repair.  
         
Together our findings support a model where 
dysregulated cell cycle progression and evasion of cell 
cycle checkpoints promotes age-related hyper-
proliferation and expansion of actively cycling IESC, 
increasing cellular stress, DNA damage, and leading to 
increased apoptosis and impaired IESC function (Figure 
8). This model is consistent with aging-associated 
dysfunction and loss of stem cell populations in other 
organs [54]. Observed increases in proliferation of 
Sox9-EGFPHigh cells, indicate that reserve, activatable 
IESC are mobilized to compensate for hyper-
proliferation but impaired function of actively cycling 
IESC. Age-associated IESC hyperproliferation may be 
necessary to support increased villus height, compen-
sate for increased villus apoptosis and maintain functions 
of the intestinal epithelium with aging. Our identification 
of mediators specifically altered in IESC from old mice 
provides a basis for translational studies of mediators and 
pathways of IESC aging in humans and to identify 
potential targets for new approaches or therapies that may 
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intestine. Importantly, our IESC-reporter mice provide 
the models for preclinical studies of the effect of potential 
interventions specifically on IESC aging.  
 




Sox9-EGFP mice on an outbred CD-1 background were 
maintained as heterozygotes and genotyped as 
previously described [24, 28]. Lgr5-EGFP-IRES-
CreERT2 (Lgr5-EGFP) mice on a C57BL/6 background 
were ordered from The Jackson Laboratory (Bar 
Harbor, ME) and maintained as heterozygotes. Original 
Lgr5-LacZ mice on a mixed background were 
generously provided by Lexicon Pharmaceuticals (The 
Woodlands, TX). Lgr5-LacZ mice on C57BL/6 back-
ground that were used in this study were generated after 
10 generations of backcrossing the original Lgr5-LacZ 
mice with C57BL/6 wild type mice. Young mice studied 
were 2 to 4 months old. Old mice were 18 to 24 months 
old. Young and old female and male mice were studied. 
For the old study groups, females were 20-24 months old 
and males 18-20 months old. These ages were selected 
based on pilot studies demonstrating no overt signs of 
disease in female or male mice at these ages.  
 
Crypt isolation and culture 
 
Jejunal crypts were isolated and in vitro crypt culture was 
performed as previously described [32]. Approximately 
30 crypts were plated into 24 well plates in 10μl Low 
Growth Factor Matrigel (BD Biosciences, Franklin 
Lakes, NJ) containing 50ng/ml EGF (R&D Systems, 
Minneapolis, MN), 100ng/ml Noggin (Peprotech, Rocky 
Hill, NJ) 1μg/ml R-spondin (R&D Systems, Minneapolis, 
MN) and 10uM Y-27632 (Sigma-Aldrich, St. Louis, 
MO). After polymerization 250μl Advanced DMEM-F12 
containing N2 supplement (Invitrogen, Carlsbad, CA), 
B27 supplement without vitamin A (Invitrogen, 
Carlsbad, CA), 10mM HEPES (Invitrogen, Carlsbad, 
CA), Glutamax (Gibco-Invitrogen, Carlsbad, CA) and 
Pen/Strep (Gibco-Invitrogen, Carlsbad, CA) was added 
to each well. Growth factors were added every 2 days at 
the same concentrations as the initial plating except R-
spondin, which was reduced to 500ng/ml. Medium was 
changed every 4 days. The number of enterospheres or 
enteroids and their complexity was recorded at days 1, 4 
and 8-post plating. Representative images of cultures 





Sox9-EGFP, Lgr5-EGFP and Lgr5-LacZ mice were 
euthanized with a lethal dose of Nembutal (150µg/g 
body weight). To identify cells in S-phase, 5-ethynyl-2’ 
deoxyuridine (EdU; Sigma-Aldrich, St. Louis, MO) was 
administered by intraperitoneal injection at a dose of 
100µg/25 g of body weight 90 minutes prior to 
Nembutal injection. The entire intestine was then 
removed and flushed with cold PBS. The jejunum was 




Intestinal segments were splayed open and fixed 
overnight in freshly made 4% paraformaldehyde at 4°C, 
washed, incubated in 10% sucrose in PBS at 4°C 
overnight and incubated in 30% sucrose in PBS at 4°C 
until embedding. Tissues were embedded in Optimal 
Cutting Temperature compound (OCT) and sectioned at 
5-7-μm thickness. Antigens were retrieved in 10mM 
sodium citrate buffer (pH=6) followed by blocking with 
10% normal goat serum. After blocking, samples were 
incubated overnight at 4°C with each of the following 
primary antibodies: GFP (1:500, chicken; Aves Labs, 
Tigard, OR), lysozyme (1:500, rabbit; Leica 
Biosystems, Buffalo Grove, IL), cleaved caspase-3 
(1:500, rabbit; Abcam, Cambridge, UK). For immuno-
fluorescence, slides were washed and incubated with the 
following secondary antibodies: goat-anti-chicken-
AlexaFluor 488 (1:400; Invitrogen, Carlsbad, CA) or 
goat-anti-rabbit-Cy3 (1:400; Jackson Immuno-Research 
Laboratories, West Grove, PA). Slides were then 
mounted using DAPI containing mounting medium 
(Electron Microscopy Sciences, Hatfield, PA) to 
visualize nuclei. Peroxidase with Vectastain avidin-
biotin complex (ABC kit; Vector Laboratories, 
Burlingame, CA) was used for immune peroxidase 
based staining. Morphometric analyses were performed 
on formalin fixed, paraffin embedded tissue cross-
sections. Tissues were washed well and slides (5-7 μm) 
were stained with hematoxylin and eosin or Phloxine 
Tartrazine and Alcian Blue. Fluorescent images were 
captured using an inverted fluorescence microscope 
(IX83; Olympus, Center Valley, PA). White light 
images were captured using an upright light microscope 
(AX10; Zeiss, Oberkochen, Germany). At least 20 
crypts were counted per animal and number of animals 
per group is indicated in figure legends.  
 
Phloxine Tartrazine and Alcian blue staining 
 
Alcian Blue Phloxine Tartrazine staining was performed 
based on previous reports [55]. Briefly, slides were 
stained with Alcian blue (Sigma-Aldrich, St. Louis, 
MO) for 30 minutes, followed by alum hematoxylin 
(BioCare, Concord, CA) for 20 seconds, staining with 
0.5% phloxine in calcium chloride (Fisher Scientific, 
Waltham, MA) for 20 minutes, and finally incubate in a 
saturated solution of tartrazine in Cellosolve (Fisher 
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Scientific, Waltham, MA) for 3-5 minutes.  Stained 




Jejunal cross sections from Lgr5-LacZ mice were 
dissected, washed with PBS, then fixed at 4º C using 
2% paraformaldehyde (PFA)/ 0.2% glutaraldehyde in 
PBS for 2 hours. Tissues were then rinsed for 20 
minutes at room temperature in 0.1M Phosphate Buffer, 
pH7.3 and permeabilized by incubation in 0.1M 
Phosphate Buffer, pH7.3 containing 0.1% Triton-X 100. 
Tissues were then transferred to X-gal solution (1g/liter 
X-Gal) in 0.1M Phosphate Buffer, pH7.3 with 5 
mmol/liter of potassium ferrocyanide, 5 mmol/liter of 
potassium ferricyanide and 0.1% Triton X-100) 
overnight in the dark at room temperature. Tissues were 
then washed twice with PBS and post-fixed in 4% 
paraformaldehyde at 4ºC overnight. Subsequently, 
tissue was washed, dehydrated in 70% ethanol and 
embedded in paraffin. 5-7 μm sections were 
counterstained with nuclear fast red and observed using 
light microscopy. At least 40 crypts were counted per 
animal and number of animals per group is indicated in 
figure legends. 
 
Intestinal epithelial cell isolation, flow cytometry and 
FACS 
 
Intestinal epithelial cells were isolated from the jejunum 
of young and old Sox9-EGFP mice for flow cytometry 
as previously described [25]. Dissociated intestinal 
epithelium was stained with propidium iodide solution 
(Sigma-Aldrich, St. Louis, MO) to exclude dead cells. 
To assess the proportion of Sox9-EGFP cells in S-phase 
by flow cytometry, an equal number of dissociated 
intestinal epithelial cells was fixed and stained for EdU 
using the Click-it EdU AlexaFluor 594 Kit and 
following the manufacturer’s instructions (Invitrogen, 
Carlsbad, CA). Gates were placed based on levels of 
Sox9-EGFP expression and back gating was performed 
to assess the percentage of cells incorporating EdU in 
each Sox9-EGFP expressing cell population. 
Quantification of different Sox9-EGFP expressing 
populations was performed using a Cyan flow 
cytometer and Summit software v4.3 (Beckman 
Coulter, Brea CA). FACS on Sox9-EGFP cells for 
population analysis was performed using the MoFlow 
XDP cell sorter (Beckman Coulter, Brea, CA). FACS 
on Sox9-EGFP cells for single cell analysis was 
performed using the SH800Z cell sorter (Sony 
Biotechnology Inc., San Jose, CA).  Immune cells were 
excluded from the sort by gating out CD31+ 
(BioLegend, San Diego, CA) and CD45+ (BioLegend, 
San Diego, CA) cells. Dead/dying cells were excluded 
from the sort by gating out SytoxBlue+ (ThermoFisher 
Scientific, Waltham, MA) and Annexin V+ (Invitrogen, 
Carlsbad, CA) cells. Cells were sorted into Sorting 
Medium composed of Advanced DMEM/F12, 100x N2 
Supplement, 50x B27 Supplement, 1mM HEPES), 100x 
Penicillin/Streptomycin, 100x Glutamax all from 
(Gibco-Invitrogen, Carlsbad, CA) and supplemented 
with 10uM Y27632 (Invitrogen, Carlsbad, CA), and 
1mM N-Acetylcysteine (NAC; Sigma-Aldrich, St. 
Louis, MO). 
 
High throughput cell population qRT-PCR using 
Fluidigm 
 
Total RNA was isolated from FACS sorted Sox9-EGFP 
populations using the RNAqueous-Micro Total RNA 
Isolation Kit (Ambion-ThermoFisher Scientific, 
Waltham, MA) according to the manufacturer’s 
instructions. RNA was quantified by measuring 
absorption at 260 nm using a Nanodrop photometer 
(Tecan, Morrisville, NC) and underwent DNase 
treatment to remove genomic DNA. Reverse 
transcription was performed on 25 μg RNA using Cells 
Direct One-Step qRT-PCR Kit (Invitrogen, Carlsbad, 
CA). Specific target amplification (STA) of 96 genes 
was performed on cDNA from the different FACS 
sorted populations isolated from Sox9-EGFP mice using 
Taqman primers purchased from Applied Biosystems. 
These target genes included population specific 
markers, genes that stimulate cell proliferation, 
apoptosis, DNA damage and maintain homeostasis. 
Preparation and loading of Fluidigm 2 x 48.48 Dynamic 
Array integrated fluidic circuit (IFC) was performed 
according to the manufacturer’s instructions (Fluidigm, 
South San Francisco, CA). Briefly, the chip was primed, 
loaded with samples and primer reaction mixes and run 
on the BioMark™ HD System. Data analysis was 
accomplished with the Fluidigm Real-Time PCR 
Analysis software. Resulting cycle threshold (Ct) values 
were analyzed by calculating the relative gene 
expression (fold change) using the 2-ΔΔCt method [56]. 
β-actin was used as the reference gene to normalize 
mRNA input and allow accurate comparisons of results 
between samples. An unsorted, pooled RNA sample 
was set as the control sample to which all other samples 
were compared. GraphPad Prism 5 was used to perform 
a 1-way ANOVA with Bonferroni post-hoc test to test 
for differences in levels of mRNA across different cell 





Data are expressed as mean ± SEM. For histology 
morphometry, histology, flow cytometry and in vitro 
culture experiments, unpaired Student’s t-tests were 
performed to compare data from young and old mice. 
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For high throughput qRT-PCR experiments one-way 
ANOVA with Bonferroni post hoc test was performed 
for comparisons of multiple groups. A P value of less 
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Gene TaqMan ID Pathway 
Bbc3 Mm00519268_m1 Apoptosis 
Ccnd1 Mm00432359_m1 Cell Cycle 
Cdk6 Mm00432051_m1 Cell Cycle 
Ephb2 Mm01181021_m1 Cell Cycle 
H2afx Mm00515990_s1 Oxidative Stress 
Irs1 Mm01278327_m1 Apoptosis 
Max Mm00484802_g1 Cell Cycle 
Nrf2 Mm00477784_m1 Oxidative Stress 
Notch2 Mm00803077_m1 Cell Cycle 
p21  Mm00432448_m1 Cell Cycle 
p53  Mm01731290_g1 DNA Damage and Apoptosis 
Perp Mm00480750_m1 Apoptosis 
Pten Mm00477208_m1 Cell Cycle 
Yap1 Mm01143263_m1 Cell Cycle 
